Limited Partners
|
Contact Us
About Us
Portfolio
Our Team
News & Events
For Entrepreneurs
Portfolio Company News
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
Aurora News
Newsletters
Events
Speaking Engagements
Portfolio Company News, 2011
December 20
Argos Therapeutics - How Ralph Steinman Raced to Develop a Cancer Vaccine – And Save His Life
December 19
EUROPEAN PATENT OFFICE GRANTS METABOLON PATENT FOR DETERMINING METABOLIC AGE OF AN INDIVIDUAL
December 15
METABOLON APPOINTS ERIC BUTTON SENIOR VICE PRESIDENT OF DIAGNOSTICS
December 13
METABOLON EXTENDS BIOCHEMICAL UNDERSTANDING OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
November 14
Regado Biosciences, Inc. Presents Three Abstracts Pertaining to its Pipeline of Reversible Antithrombotic Agents, Including the Substudy Analyses of its Phase 2b RADAR trial for REG1, its lead product candidate, at the American Heart Association (AHA) Scientific Sessions 2011 Meeting
October 19
METABOLOMICS INSIGHT INTO PERIODONTAL DISEASE PUBLISHED IN THE JOURNAL OF DENTAL RESEARCH
October 17
METABOLON AND SHANGHAI JIAO TONG UNIVERSITY OPEN METABOLOMICS LAB IN CHINA
October 4
Argos Therapeutics’ Late Scientific Co-founder Ralph Steinman, M.D., Awarded Nobel Prize in Medicine for Discovery of Dendritic Cells as Critical Sentinels of Immune System
September 1
REGADO BIOSCIENCES, INC. - THE ANTITHROMBOTIC CONUNDRUM: IS REG1 A GAME CHANGER?
August 29
METABOLON SECURES $13 MILLION IN SERIES D FINANCING
June 9
METABOLOMICS STUDY PROVIDES INSIGHT INTO OVARY METABOLOME AND CANCER-ASSOCIATED METABOLIC CHANGES REPORT INVESTIGATORS FROM UNIVERSITY OF LOUISVILLE AND METABOLON
June 1
Argos Therapeutics’ Arcelis™ Immunotherapy for the Treatment of Renal Cell Carcinoma (RCC) in Combination with Sunitinib Demonstrates Strong Immunologic Response That Correlates to Improved Clinical Outcomes
May 19
Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System
May 13
Metabolon Featured in The News and Observer
April 3
Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System
March 29
Centice Corporation Places PINPOINT Rx™ into Major New England Hospital
February 8
METABOLON AWARDED PATENT FOR BIOCHEMICAL ANALYSIS PLATFORM
February 4
Centice Corporation Announces New Executive Vice President of Sales and Business Development
January 7
Centice - PASS Rx/PINPOINT Rx featured on local news
January 6
METABOLOMICS PROVIDES INSIGHT INTO PATHOGENESIS OF DILATED CARDIOMYOPATHY
January 5
Aldagen Announces FDA Clearance of IND to begin Phase 2 Study in Ischemic Stroke with Regenerative Cell Therapy
About Us
Portfolio
Our Team
News & Events
For Entrepreneurs
©2002–2013 The Aurora Funds, Inc.